143 related articles for article (PubMed ID: 22330339)
1. CD14- mononuclear stromal cells support (CD14+) monocyte-osteoclast differentiation in aneurysmal bone cyst.
Taylor RM; Kashima TG; Hemingway FK; Dongre A; Knowles HJ; Athanasou NA
Lab Invest; 2012 Apr; 92(4):600-5. PubMed ID: 22330339
[TBL] [Abstract][Full Text] [Related]
2. Osteoclast formation and function in pigmented villonodular synovitis.
Taylor R; Kashima TG; Knowles H; Gibbons CL; Whitwell D; Athanasou NA
J Pathol; 2011 Sep; 225(1):151-6. PubMed ID: 21706481
[TBL] [Abstract][Full Text] [Related]
3. Multinucleated giant cells in various forms of giant cell containing lesions of the jaws express features of osteoclasts.
Liu B; Yu SF; Li TJ
J Oral Pathol Med; 2003 Jul; 32(6):367-75. PubMed ID: 12787044
[TBL] [Abstract][Full Text] [Related]
4. Cellular mechanisms of osteoclast formation and lacunar resorption in giant cell granuloma of the jaw.
Itonaga I; Hussein I; Kudo O; Sabokbar A; Watt-Smith S; Ferguson D; Athanasou NA
J Oral Pathol Med; 2003 Apr; 32(4):224-31. PubMed ID: 12653862
[TBL] [Abstract][Full Text] [Related]
5. VEGF, FLT3 ligand, PlGF and HGF can substitute for M-CSF to induce human osteoclast formation: implications for giant cell tumour pathobiology.
Taylor RM; Kashima TG; Knowles HJ; Athanasou NA
Lab Invest; 2012 Oct; 92(10):1398-406. PubMed ID: 22906984
[TBL] [Abstract][Full Text] [Related]
6. Synovial macrophage-osteoclast differentiation in inflammatory arthritis.
Danks L; Sabokbar A; Gundle R; Athanasou NA
Ann Rheum Dis; 2002 Oct; 61(10):916-21. PubMed ID: 12228163
[TBL] [Abstract][Full Text] [Related]
7. Cellular and humoral mechanisms of osteoclast formation in Ewing's sarcoma.
Lau YS; Adamopoulos IE; Sabokbar A; Giele H; Gibbons CL; Athanasou NA
Br J Cancer; 2007 Jun; 96(11):1716-22. PubMed ID: 17533390
[TBL] [Abstract][Full Text] [Related]
8. Effect of osteoprotegerin and osteoprotegerin ligand on osteoclast formation by arthroplasty membrane derived macrophages.
Itonaga I; Sabokbar A; Murray DW; Athanasou NA
Ann Rheum Dis; 2000 Jan; 59(1):26-31. PubMed ID: 10627423
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic and molecular studies of giant-cell tumors of bone and soft tissue.
Lau YS; Sabokbar A; Gibbons CL; Giele H; Athanasou N
Hum Pathol; 2005 Sep; 36(9):945-54. PubMed ID: 16153456
[TBL] [Abstract][Full Text] [Related]
10. Malignant melanoma and bone resorption.
Lau YS; Sabokbar A; Giele H; Cerundolo V; Hofstetter W; Athanasou NA
Br J Cancer; 2006 May; 94(10):1496-503. PubMed ID: 16641914
[TBL] [Abstract][Full Text] [Related]
11. RANK signalling in bone lesions with osteoclast-like giant cells.
Won KY; Kalil RK; Kim YW; Park YK
Pathology; 2011 Jun; 43(4):318-21. PubMed ID: 21532526
[TBL] [Abstract][Full Text] [Related]
12. Osteoclast differentiation from circulating mononuclear precursors in Paget's disease is hypersensitive to 1,25-dihydroxyvitamin D(3) and RANKL.
Neale SD; Smith R; Wass JA; Athanasou NA
Bone; 2000 Sep; 27(3):409-16. PubMed ID: 10962353
[TBL] [Abstract][Full Text] [Related]
13. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.
Quinn JM; Horwood NJ; Elliott J; Gillespie MT; Martin TJ
J Bone Miner Res; 2000 Aug; 15(8):1459-66. PubMed ID: 10934644
[TBL] [Abstract][Full Text] [Related]
14. Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand.
Udagawa N; Takahashi N; Jimi E; Matsuzaki K; Tsurukai T; Itoh K; Nakagawa N; Yasuda H; Goto M; Tsuda E; Higashio K; Gillespie MT; Martin TJ; Suda T
Bone; 1999 Nov; 25(5):517-23. PubMed ID: 10574571
[TBL] [Abstract][Full Text] [Related]
15. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
[TBL] [Abstract][Full Text] [Related]
16. Osteoprotegerin and osteoprotegerin ligand effects on osteoclast formation from human peripheral blood mononuclear cell precursors.
Shalhoub V; Faust J; Boyle WJ; Dunstan CR; Kelley M; Kaufman S; Scully S; Van G; Lacey DL
J Cell Biochem; 1999 Feb; 72(2):251-61. PubMed ID: 10022507
[TBL] [Abstract][Full Text] [Related]
17. In vitro differentiation of CD14 cells from osteopetrotic subjects: contrasting phenotypes with TCIRG1, CLCN7, and attachment defects.
Blair HC; Borysenko CW; Villa A; Schlesinger PH; Kalla SE; Yaroslavskiy BB; Garćia-Palacios V; Oakley JI; Orchard PJ
J Bone Miner Res; 2004 Aug; 19(8):1329-38. PubMed ID: 15231021
[TBL] [Abstract][Full Text] [Related]
18. Increased osteoclast formation and activity by peripheral blood mononuclear cells in chronic liver disease patients with osteopenia.
Olivier BJ; Schoenmaker T; Mebius RE; Everts V; Mulder CJ; van Nieuwkerk KM; de Vries TJ; van der Merwe SW
Hepatology; 2008 Jan; 47(1):259-67. PubMed ID: 18022900
[TBL] [Abstract][Full Text] [Related]
19. Roles of stromal cell RANKL, OPG, and M-CSF expression in biphasic TGF-beta regulation of osteoclast differentiation.
Karst M; Gorny G; Galvin RJ; Oursler MJ
J Cell Physiol; 2004 Jul; 200(1):99-106. PubMed ID: 15137062
[TBL] [Abstract][Full Text] [Related]
20. In vitro generation of mature human osteoclasts.
Hemingway F; Cheng X; Knowles HJ; Estrada FM; Gordon S; Athanasou NA
Calcif Tissue Int; 2011 Nov; 89(5):389-95. PubMed ID: 21960377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
